Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (12431)	12/11/1999 8:55:00 PM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

George, you think it might be important that the best minds in the country at Harvard think they have finally found the the answer of why neonates are more prone to gram neg bugs? YOU think that might be important?LOL Isn't it more important to see how much Castello makes and what Manny says? Unbelievable just unbelievable. Let's see......how closely will ALL neonates be watched for signs of gram neg bugs and what will be waiting in the wings IF approved when signs first appear? Hmmmmmmmmm. Cost? What will the cost be if neonate is not treated and has bad outcome? Hmmmmmmmm. Do you think now the Harvard fellows with their brain power are cooking up ideas for new trials? Hmmmmmmm. Xoma can sure keep things quiet.......you betcha!